Evidence map›Paper›PMID 18703762›Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2008

Coenzyme Q1 redox metabolism during passage through the rat pulmonary circulation and the effect of hyperoxia.

Said H Audi, Marilyn P Merker, Gary S Krenz, Taniya Ahuja, David L Roerig, Robert D Bongard

Open access · greenAbstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. In vivo molecular imaging stratifies rats with different susceptibilities to hyperoxic acute lung injury.American journal of physiology. Lung cellular and molecular physiology · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Differential lung uptake of 99mTc-hexamethylpropyleneamine oxime and 99mTc-duramycin in the chronic hyperoxia rat model.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2012
    Article
  11. Article
  12. Article
  13. Article
  14. Differential responses of targeted lung redox enzymes to rat exposure to 60 or 85% oxygen.Journal of applied physiology (Bethesda, Md. : 1985) · 2011
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Said H AudiResearch Service 151, Zablocki VAMC, 5000 W. National Avenue, Milwaukee, WI 53295, USA. audis@mu.edu
Marilyn P Merker
Gary S Krenz
Taniya Ahuja
David L Roerig
Robert D Bongard
Milwaukee VA Medical Center · US

Funding

LUNG METABOLISM OF VASOACTIVE HORMONESR01HL024349 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI AUDI, SAID H · 1985 to 2010
$2.1M
REDOX ACTIVITY OF THE PULMONARY ENDOTHELIAL SURFACER01HL065537 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI MERKER, MARILYN P · 2000 to 2008
$1.6M
NHLBI NIH HHS HL 24349NHLBI NIH HHS HL 65537NHLBI NIH HHS R01 HL024349NHLBI NIH HHS R01 HL065537
6 · The paper itself

Abstract

The objective was to evaluate the pulmonary disposition of the ubiquinone homolog coenzyme Q(1) (CoQ(1)) on passage through lungs of normoxic (exposed to room air) and hyperoxic (exposed to 85% O(2) for 48 h) rats. CoQ(1) or its hydroquinone (CoQ(1)H(2)) was infused into the arterial inflow of isolated, perfused lungs, and the venous efflux rates of CoQ(1)H(2) and CoQ(1) were measured. CoQ(1)H(2) appeared in the venous effluent when CoQ(1) was infused, and CoQ(1) appeared when CoQ(1)H(2) was infused. In normoxic lungs, CoQ(1)H(2) efflux rates when CoQ(1) was infused decreased by 58 and 33% in the presence of rotenone (mitochondrial complex I inhibitor) and dicumarol [NAD(P)H-quinone oxidoreductase 1 (NQO1) inhibitor], respectively. Inhibitor studies also revealed that lung CoQ(1)H(2) oxidation was via mitochondrial complex III. In hyperoxic lungs, CoQ(1)H(2) efflux rates when CoQ(1) was infused decreased by 23% compared with normoxic lungs. Based on inhibitor effects and a kinetic model, the effect of hyperoxia could be attributed predominantly to 47% decrease in the capacity of complex I-mediated CoQ(1) reduction, with no change in the other redox processes. Complex I activity in lung homogenates was also lower for hyperoxic than for normoxic lungs. These studies reveal that lung complexes I and III and NQO1 play a dominant role in determining the vascular concentration and redox status of CoQ(1) during passage through the pulmonary circulation, and that exposure to hyperoxia decreases the overall capacity of the lung to reduce CoQ(1) to CoQ(1)H(2) due to a depression in complex I activity.

Indexed as

Pulmonary CirculationAnimalsDisease Models, AnimalElectron Transport Complex IElectron Transport Complex IIIEnzyme InhibitorsHyperoxiaKineticsLungMitochondriaModels, CardiovascularNAD(P)H Dehydrogenase (Quinone)Oxidation-ReductionOxidoreductasesRatsRats, Sprague-DawleyElectron Transport Complex IElectron Transport Complex IIIEnzyme InhibitorsNAD(P)H Dehydrogenase (Quinone)NQO1 protein, ratOxidoreductasesUbiquinoneUbiquinone Q1

Identifiers

PMID18703762
PMCPMC2576032
OpenAlexW2060201843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.